Why did CCEL stock fall pre-market on 16 Mar 2026?

The drop followed a NYSE American non-compliance notice and heavy selling. Pre-market volume rose to **29,717** versus average **12,358**, signaling concentrated exits tied to listing concerns.

What is Meyka AI's forecast for CCEL stock?

Meyka AI's model projects a monthly price of **$2.22**, a quarterly price of **$1.60**, and a yearly price of **$1.84**. These are model projections and not guarantees.

How does valuation look for CCEL stock right now?

Valuation shows **EPS -0.30**, **PE -9.73**, price-to-sales **0.74**, negative book value per share **-2.31**, and free cash flow yield **22.54%**, a mixed fundamental picture.

Should I trade CCEL stock now given the volatility?

Trading CCEL stock now is high risk. Watch regulatory updates, bid-ask spreads, and volume. Small market cap and compliance notices raise listing and liquidity risks.

US Stocks

CCEL (Cryo-Cell) NASDAQ pre-market -100.00% 16 Mar 2026: check listing risk

ByDanny Kontos March 16, 2026March 16, 2026

The CCEL stock plunged in pre-market trade on 16 Mar 2026, reflecting a near-total price collapse and a fresh NYSE American compliance notice. Traders show unusually high activity with volume 29,717 versus average 12,358, while the quote data lists a day high of $3.12 and a reported open and prior close of $3.11. This note explains drivers, valuation, technical signals, Meyka AI grading, and short-term forecasts for Cryo-Cell International, Inc. (NASDAQ) to help investors weigh listing and liquidity risk.